FAST — Fastenal Company

The market's read as of 2026-10-14 is cautious-neutral, not bearish. Q3 2026 (reported 2026-10-14) showed net sales +15.5% YoY to $2.463B, diluted EPS +19.8% to $0.35 (vs $0.34 consensus), and operating margin up 90bps YoY to 21.5% - a genuinely good quarter. But the stock still fell 4.11% to $49.315 on the print, and is down 4.67% over the week, because Fastenal trimmed FY2026 device signings to 27,000-29,000 weighted machine equivalents and gross margin compressed to 44.8% from 45.3% on a mix shift toward large contract accounts. Sell-side is split and unenthusiastic: 11 Buy, 19 Hold, 2 Sell, with a $51 consensus target and a $47 low - roughly flat-to-negative versus the 2026-10-14 price. Investors are not questioning the near-term earnings; they are questioning whether the vending/onsite growth engine that justifies a premium multiple is losing momentum.

Revenue is accelerating, not decelerating, and has been for five straight quarters: YoY growth ran +11.7% in Q3 2025 ($2.133B vs $1.910B), +11.1% in Q4 2025 ($2.027B vs $1.825B), +12.4% in Q1 2026 ($2.202B vs $1.959B), +14.7% in Q2 2026 ($2.387B vs $2.080B), and +15.5% in Q3 2026 ($2.463B vs $2.133B). EPS follows: $0.26, $0.26, $0.30, $0.33, $0.35 sequentially through 2025-26, with Q3 2026 EPS +20.7% YoY versus Q3 2025's $0.29. This is a real inflection, not a blip - the driver is large/contract customer revenue (+18.8%) and heavy manufacturing daily sales (+20.2%). The important nuance: gross margin is compressing structurally, not temporarily, running ~40-75bps below year-ago each quarter (Q3 2026 44.85% vs 45.27%; Q2 2026 44.56% vs 45.32%; Q1 2026 44.64% vs 45.11%) as mix shifts to bigger, lower-margin accounts. What has rescued operating margin is SG&A leverage on those same larger accounts: operating margin went 20.10% to 20.33% (Q1), 20.96% to 21.02% (Q2), and 20.70% to 21.55% (Q3 2026). So far the mix trade is net positive - but it means the margin story now depends entirely on cost leverage holding, with no gross-margin cushion left.

Expensive, and expensive against its own history as of 2026-10-14. TTM P/E is 39.77 versus a 5-year average of 33.89 (a ~17% premium); P/S is 6.23 versus a 5-year average of 5.23 (~19% premium); P/B is 13.64, EV/EBITDA is 28.45, and PEG is 2.50 on a mid-teens growth rate. Forward P/E is roughly 38.9x on the $1.269 next-FY consensus EPS (which itself looks stale against the Q1-Q3 2026 run-rate of $0.98), or about 34x on my own forward-12-month EPS estimate of ~$1.45. The 2.0% dividend yield and 1.9% TTM FCF yield ($1.053B FCF on a $56.6B market cap) offer little valuation support. Verdict: this is a premium business at a premium-to-its-own-history price - justified by 28.2% ROIC, 15.6% net margin and a fortress balance sheet, but with no margin of safety if growth normalizes.

The stock is not mispricing earnings - it is mispricing durability. Q3 2026 earnings already beat ($0.35 vs $0.34) and operating margin expanded 90bps, yet the shares fell 4.11% to $49.315 on 2026-10-14. That tells you the multiple, not the EPS, is what's in play: at ~39.8x TTM, a de-rating toward the 33.9x 5-year average on unchanged earnings is roughly a 15% drawdown, and that is the single biggest risk here. The bull case requires only that monthly device signings stabilize and operating margin keeps expanding - then EPS beats continue and 34x forward holds. The bear case is that the FASTBin target cut is the leading edge of slower contract-customer growth, in which case revenue decelerates into a still-rich multiple. Watch the monthly sales releases for device signings before anything else; that is the tell, not the P&L.

As of 2026-10-14, RSI-14 stood at 35.67 - weak, but not yet the sub-30 oversold reading you want for a high-quality name. The price closed at $49.315 (previous close $51.43), which is 5.37% below the 20-day SMA and 5.54% below the 50-day SMA, but still 2.01% above the 200-day SMA. Returns: -4.67% over one week, -3.91% over one month, but +4.73% over three months and +6.99% over six months. Read: a sharp short-term pullback inside an intact longer-term uptrend, with the 52-week range at $38.97-$52.92. The 200-day is the line that matters for the thesis; a decisive break below it would confirm the market is re-rating the growth story, while a hold here plus a stabilization in RSI would look like an ordinary post-guidance haircut. Entry-timing implication: this is not a washed-out entry - waiting for either an RSI push into the low 30s or a reclaim of the 50-day would be the disciplined approach.

• Industrial production and heavy manufacturing are stabilizing/expanding - Fastenal posted +20.2% daily sales growth in heavy manufacturing in Q3 2026, but this is a cyclical end market and monthly comps will roll over quickly in a downturn.
• Non-residential construction has now grown for six consecutive quarters, supporting the construction side of MRO demand and Fastenal's larger contract accounts (+18.8% in Q3 2026).
• Elevated capex of $310M-$330M planned for FY2026 (IT investment, the Atlanta hub replacement, higher logistics/trucking costs) is suppressing near-term free cash flow and cash conversion.
• Working capital stretch - strong top-line growth with larger accounts has lengthened accounts receivable collection, creating temporary operating cash flow timing pressure (described in the Q3 2026 brief).
• A high-for-longer rate backdrop compresses the multiple on a ~40x trailing P/E quality compounder more than it hurts the P&L, given a beta of 0.69 and debt/equity of just 0.109 - this is a discount-rate risk, not a solvency risk.

• Monthly sales releases (typically early in the month, next one following the 2026-10-14 print) tracking whether FASTBin/FASTVend device signings stabilize near the trimmed 27,000-29,000 target or continue to slide - the single most important forward indicator.
• Q4 2026 / FY2026 earnings on 2027-01-14 (estimated), including initial FY2027 framing and any further device-signing guidance reset.
• Execution updates on the Atlanta hub replacement and technology deployment - success here supports the cost-leverage leg that is currently carrying operating margin.
• Continuation of the operating-margin expansion trend (Q3 2026 +90bps YoY to 21.5%) despite gross-margin compression - proof the large-account mix shift is accretive to operating profit.
• Industrial production and non-residential construction data points - any reacceleration would amplify Fastenal's already-accelerating revenue trend.

• The FASTBin/FASTVend device-signing target cut (28,000-30,000 to 27,000-29,000) may be the first sign of a structural slowdown in the embedded-inventory growth engine, which is the core of the premium-multiple thesis.
• Gross margin erosion is structural, not a one-off: 44.8% vs 45.3% YoY in Q3 2026, with Q1-Q3 2026 all running 40-75bps below year-ago levels on large-account mix. If SG&A leverage ever stalls, operating margin reverses with it.
• Valuation leaves no cushion - 39.77x TTM P/E vs a 33.89x 5-year average, 6.23x sales, 28.45x EV/EBITDA. A re-rating toward the historical multiple is roughly a 15% downside on unchanged earnings.
• Weak cash conversion: TTM free cash flow of ~$1.053B against a $56.6B market cap is a ~1.9% FCF yield, with receivables stretching as larger customers lengthen collection cycles.
• Cyclical exposure - heavy manufacturing (+20.2% in Q3 2026) and non-residential construction are the growth engines, and both are late-stage beneficiaries of a mature industrial cycle.

Fastenal is a genuinely excellent business - 28.2% ROIC, 15.6% net margin, 0.109 debt/equity, 21.5% operating margin that is still expanding, and revenue growth accelerating for five consecutive quarters to +15.5% YoY in Q3 2026. The problem is that the 2026-10-14 price of $49.315 already embeds all of it at 39.77x trailing earnings and 6.23x sales, and the same quarter that delivered the beat delivered the first real crack in the vending-device growth narrative. This is a hold, not a buy: quality worth owning, price worth waiting on. A move into the low-to-mid $40s, or evidence in the monthly sales releases that device signings have stabilized, would make it interesting.

I applied a justified forward P/E of 33x - a slight discount to Fastenal's own 5-year average of 33.89x, reflecting the FASTBin/FASTVend signing deceleration and structural gross-margin mix compression, offset by 28.2% ROIC and the expanding 21.5% operating margin - to a forward-12-month EPS estimate of ~$1.45 (built from the $1.269 next-FY consensus grown at ~13-15%, consistent with Q3 2026's +19.8% EPS growth), giving $47.85. Note that a raw DCF on TTM FCF of $1.053B with an 8% WACC yields a far lower figure near $30, which I treat as an artifact of Fastenal's historically low FCF yield rather than a usable anchor; the own-history earnings multiple is the more honest lens for this business.